- Expression-based, consistent biomarkers for prognosis and diagnosis in lung cancerM., Arroyo; R., Larrosa; J., Gómez-Maldonado; M. Á., Cobo; M. G., Claros; R., BautistaClinical & Translational Oncology, 2020, 22(10): 1867-1874.被引 1
- In-depth genomic characterization of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients.Kang, Li; Liu, Jun; Li, Jia; Wu, Lin; Xiao, Yajie; Du, Haijian; Zhao, Zhikun; Li, Xiaoting; Wu, Dongfang; Zhao, Zhuxiang; Chen, BolinVirtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2021-06-04 To 2021-06-08.
- ASO Author Reflections: Expression Changes in Programmed Death Ligand 1 in Subcentimeter Lung AdenocarcinomaYang, Xiongwen; Zhong, Wen-Zhao*Annals of Surgical Oncology, 2023, 30(12): 7499-7500.
期刊论文
Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancer
14阅读
